-
“Six Fewer Needles*!” — Peking University First Hospital Reports Breakthrough in Precision Prostate Biopsy, Published in The Lancet Sub-Journal
On November 14, a research team led by Prof. Kan Gong and Associate Chief Physician Yi Liu from the Department of Urology, Peking University First Hospital and the Institute of Urology, Peking University, published a major advancement in precision prostate biopsy in eClinicalMedicine, a sub-journal of The Lancet.
-
Junhua Zheng/ Wei Zhai Team Develops Multimodal AI Model for Kidney Cancer, Published in a Nature Sub-Journal
Recently, the urology team led by Prof. Junhua Zheng and Researcher Wei Zhai from the Department of Urology, Renji Hospital, Shanghai Jiao Tong University School ofkk Medicine, together with multiple collaborating centers, achieved a major breakthrough in precision prognosis of kidney cancer. Their multimodal prediction of recurrence score (MPRS) model was successfully published in npj…
-
CCHIO Leadership Dialogue | Prof. Changling Li: From “Following” to “Leading” — China’s Global Breakthroughs and New Directions in Precision Urologic
From November 6–9, 2025, the China Congress of Holistic Integrative Oncology (CCHIO 2025) was held in Kunming. The conference was hosted by the China Anti-Cancer Association (CACA) and the Tengchong Scientist Forum Organizing Committee, co-organized by the World Association of Integrative Oncology (WAIO) and the China Academy of Integrative Medicine, and jointly undertaken by Yunnan…
-
ASH 2025 Highlights: Expert Dialogue on MDS & AML
Honored to share insights from the 67th ASH Annual Meeting, featuring an in-depth conversation with Prof. Mikkael A. Sekeres and Prof. Huafeng Wang. The discussion explores key updates and clinical…
-
Professors Huafeng Wang and Mikkael Sekeres Discuss ASH Guidelines Update for Elderly AML Patients and Its Implications for Treatment Pathways in China
On December 7th, local time, the highly anticipated session on the “Updated ASH Clinical Practice Guidelines on Acute Myeloid Leukemia (AML) in Older Adults” was successfully held at the American Society of Hematology (ASH) Annual Meeting. This session was chaired by Professor Mikkael Sekeres, the lead expert of the ASH guidelines and Director of the…
-
ASH China Voice丨Xingyu Cao / Wei Ma / Yunchao Su: New Progress in Treating CMV Infection, EBV Viremia, and PTLD After Allogeneic HSCT
From December 6–9, 2025, the 67th American Society of Hematology (ASH) Annual Meeting was held in Orlando, USA. As one of the world’s largest and most influential academic events in…
-
Professor Ning-NingLu: Precision Radiotherapy in Urologic Malignancies: State-of-the-Art Clinical Practices and Emerging Strategies
With China’s population undergoing demographic aging and growing public awareness of cancer screening, the clinical need for the management of urologic malignancies is steadily increasing. Radiotherapy, a mainstay of oncologic treatment, has evolved rapidly—progressing from old techniques to intensity‑modulated radiotherapy (IMRT), and from conventional fractionation regimens to stereotactic body radiation therapy (SBRT). Precision radiotherapy is…
-
NCCU 2025丨Prof. Shan Zheng: Piercing Through the Pink — How to Overcome Diagnostic and Prognostic Challenges in Eosinophilic Renal Tumors?
Editor’s note: The incidence of genitourinary cancers in China has continued to rise, with prostate, bladder, and kidney cancers ranking among the most common malignancies. Among them, eosinophilic renal tumors…
Connecting Medical Expertise through Media